Sakiyalak Pranya, Slisatkorn Worawong, Pornratanarangsi Suwatchai, Wongpraparut Nattawut, Jakrapanichakul Decho, Raksamani Kasana, Prakanrattana Ungkab, Laksanabunsong Pansak
Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 2012 Jan;95(1):124-8.
Aortic valve replacement (AVR) is the standard treatment for patients with symptomatic severe aortic stenosis (AS). However many patients are not offered surgery due to high surgical risk for open AVR. Transcatheter aortic valve implantation has been an alternative to open heart surgery in patients with symptomatic severe aortic stenosis (AS) who are not suitable for open surgery. The first transcatheter aortic valve implantation in Thailand via the transapical route is described. An 87-year-old woman with symptomatic severe AS, calcified aorta and peripheral arterial disease, who was at high surgical risk, was successfully treated, and had good functional and haemodynamic results at six-months follow-up.
主动脉瓣置换术（AVR）是有症状的重度主动脉瓣狭窄（AS）患者的标准治疗方法。然而，由于开胸主动脉瓣置换术的手术风险高，许多患者未接受手术治疗。对于有症状的重度主动脉瓣狭窄且不适合开胸手术的患者，经导管主动脉瓣植入术已成为心脏直视手术的替代方法。本文描述了泰国首例经心尖途径的经导管主动脉瓣植入术。一名87岁有症状的重度主动脉瓣狭窄、主动脉钙化和外周动脉疾病且手术风险高的女性患者成功接受了治疗，在六个月的随访中功能和血流动力学结果良好。
